We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-6.57%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$992B
AUM Growth
-$120B
Cap. Flow
-$16.9B
Cap. Flow %
-1.7%
Top 10 Hldgs %
27.94%
Holding
3,085
New
108
Increased
1,637
Reduced
1,059
Closed
107

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$4.45B
2
JPM icon
JPMorgan Chase
JPM
+$2.22B
3
TEAM icon
Atlassian
TEAM
+$2.08B
4
NVDA icon
NVIDIA
NVDA
+$1.81B
5
AAPL icon
Apple
AAPL
+$1.67B

Sector Composition

Rank Sector Weight
1 Technology 26.79%
2 Healthcare 17.19%
3 Consumer Discretionary 15.16%
4 Financials 10.74%
5 Communication Services 10.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EQH icon
226
Equitable Holdings
EQH
$14.1B
$892M 0.09%
28,851,136
-16,182,519
-36% -$533M
TOST icon
227
Toast
TOST
$19.8B
$883M 0.09%
40,644,272
+13,110,549
+48% +$296M
RARE icon
228
Ultragenyx Pharmaceutical
RARE
$2.63B
$863M 0.09%
11,884,786
+359,697
+3% +$25M
C icon
229
Citigroup
C
$232B
$856M 0.09%
16,038,813
+6,452,554
+67% +$399M
BA icon
230
Boeing
BA
$181B
$855M 0.09%
4,464,978
+317,032
+8% +$63.6M
NXPI icon
231
NXP Semiconductors
NXPI
$58.7B
$853M 0.09%
4,608,659
-1,657,693
-26% -$327M
DLTR icon
232
Dollar Tree
DLTR
$24.8B
$851M 0.09%
5,311,784
-35,122
-0.7% -$4.97M
CAH icon
233
Cardinal Health
CAH
$53.9B
$845M 0.09%
14,898,983
-129,784
-0.9% -$6.95M
RPM icon
234
RPM International
RPM
$14.4B
$840M 0.08%
10,309,745
+1,110,064
+12% +$95.3M
CAG icon
235
Conagra Brands
CAG
$7.33B
$838M 0.08%
24,949,835
+5,373,350
+27% +$183M
CASY icon
236
Casey's General Stores
CASY
$31.4B
$824M 0.08%
4,159,605
-156,963
-4% -$29.5M
SBAC icon
237
SBA Communications
SBAC
$19.6B
$814M 0.08%
2,364,457
+734,652
+45% +$238M
TSN icon
238
Tyson Foods
TSN
$19.9B
$800M 0.08%
8,922,124
-4,885,977
-35% -$446M
XP icon
239
XP
XP
$8.02B
$795M 0.08%
26,403,989
+11,693,326
+79% +$365M
PCAR icon
240
PACCAR
PCAR
$68.2B
$790M 0.08%
13,447,926
-166,449
-1% -$10.2M
PEG icon
241
Public Service Enterprise Group
PEG
$37.8B
$787M 0.08%
11,249,656
-10,247,580
-48% -$678M
MSI icon
242
Motorola Solutions
MSI
$76.4B
$784M 0.08%
3,235,176
+967,705
+43% +$225M
DAVA icon
243
Endava
DAVA
$161M
$783M 0.08%
5,883,249
+1,672,426
+40% +$211M
DSGX icon
244
Descartes Systems
DSGX
$6.35B
$778M 0.08%
10,613,248
+70,798
+0.7% +$5.1M
EFX icon
245
Equifax
EFX
$21.2B
$761M 0.08%
3,210,853
-1,064,320
-25% -$251M
NATI
246
DELISTED
National Instruments Corp
NATI
$757M 0.08%
18,652,644
-325,676
-2% -$13.1M
FE icon
247
FirstEnergy
FE
$27.3B
$756M 0.08%
16,494,606
+185,177
+1% +$7.83M
BKR icon
248
Baker Hughes
BKR
$63.1B
$755M 0.08%
20,740,670
+19,430,686
+1,483% +$590M
MSCI icon
249
MSCI
MSCI
$40.7B
$751M 0.08%
1,494,009
-768,960
-34% -$399M
BIDU icon
250
Baidu
BIDU
$35.3B
$751M 0.08%
5,672,824
-7,035
-0.1% -$1.06M

Similar funds

T. Rowe Price Associates's Q1 2022 Portfolio in Review

As of Q1 2022, T. Rowe Price Associates held 3,085 positions worth $992B, down 11% from $1.11T the previous quarter. Its ten largest holdings account for 28% of the portfolio.

T. Rowe Price Associates's Q1 2022 filing shows 108 new, 1,637 increased, 1,059 reduced and 107 closed positions. Its largest new stake was Nutrien: 6,143,560 shares worth $639M. The largest sale was Alphabet (Google) Class C, an estimated $3.24B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q1 2022 buy was Nutrien: 6,143,560 shares worth $639M.
  • T. Rowe Price Associates added most to Tesla in Q1 2022, an estimated $4.45B increase.
  • T. Rowe Price Associates's biggest Q1 2022 reduction was Alphabet (Google) Class C, cutting an estimated $3.24B.
  • T. Rowe Price Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $481M.
  • T. Rowe Price Associates's ten largest holdings make up 28% of its $992B portfolio in Q1 2022.
  • T. Rowe Price Associates opened 108 new positions and closed 107 in Q1 2022.
  • T. Rowe Price Associates's portfolio value fell 11% quarter-over-quarter to $992B.

Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.